Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4uhr | NGI | Adenosine receptor A2a |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4uhr | NGI | Adenosine receptor A2a | / | 1.000 | |
| 4ug2 | NGI | Adenosine receptor A2a | / | 0.568 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.558 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.547 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.546 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.544 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.543 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.543 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.538 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.537 | |
| 2ydv | NEC | Adenosine receptor A2a | / | 0.523 | |
| 2ydo | ADN | Adenosine receptor A2a | / | 0.516 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.512 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.506 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.504 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.497 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.494 | |
| 5g53 | NEC | Adenosine receptor A2a | / | 0.491 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.483 | |
| 1osv | CHC | Bile acid receptor | / | 0.482 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.475 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.463 | |
| 3jyn | NDP | Quinone oxidoreductase | / | 0.461 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.461 | |
| 1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.458 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.455 | |
| 4cax | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.455 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.455 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.454 | |
| 4qbj | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.449 | |
| 1lri | CLR | Beta-elicitin cryptogein | / | 0.448 | |
| 3aba | FLI | Cytochrome P450 | / | 0.448 | |
| 4d7e | FAD | Putative lysine-N-oxygenase | / | 0.448 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.448 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.447 | |
| 2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.446 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.446 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.446 | |
| 3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
| 2qo6 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.444 | |
| 3liv | E16 | Protease | / | 0.444 | |
| 3ol5 | SAW | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 2xyn | VX6 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.442 | |
| 3bhl | THG | Thymidylate synthase | / | 0.442 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.442 | |
| 3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
| 3ics | COA | Coenzyme A disulfide reductase | / | 0.441 | |
| 3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 3vg9 | ZMA | Adenosine receptor A2a | / | 0.441 | |
| 4knz | CB3 | Thymidylate synthase | / | 0.441 | |
| 1nue | GDP | Nucleoside diphosphate kinase B | 2.7.4.6 | 0.440 | |
| 1zhw | HC2 | Oxysterol-binding protein homolog 4 | / | 0.440 | |
| 3p6m | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
| 4isk | 1JY | Thymidylate synthase | / | 0.440 |